Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Needham & Company LLC 

Pacira Pharmaceuticals diskutieren

Pacira Pharmaceuticals

WKN: A1H68T / Symbol: PCRX / Name: Pacira Pharma / Aktie / Pharmazeutika / Small Cap /

20,40 €
0,99 %

7 0
7
0
Einschätzung Buy
Rendite (%) -2,88 %
Kursziel 32,74
Veränderung
Endet am 17.11.26

Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat

HC Wainwright 
0
Melden Teilen
17.11.25
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

Citigroup_Inc_ in Kimbell Royalty Partners LP diskutieren
Kimbell Royalty (KRP) had its price target raised by Citi...
31.03.26
Morgan_Stanley in Chewy Inc diskutieren
Chewy (CHWY) had its price target lowered by Morgan Stanl...
31.03.26
Susquehanna in Draftkings Inc. diskutieren, DraftKings Inc.
DraftKings (DKNG) had its price target lowered by Susqueh...
31.03.26
Piper_Sandler in AnaptysBio Inc diskutieren
AnaptysBio (ANAB) had its price target raised by Piper Sa...
31.03.26
DA_Davidson in Modine Manufacturing diskutieren
Modine Manufacturing (MOD) had its "buy" rating reaffirme...
31.03.26
Wedbush in Progress Software diskutieren
Progress Software (PRGS) had its price target lowered by ...
31.03.26
Wells_Fargo___Compan in Visteon Corporation diskutieren
Visteon (VC) had its price target lowered by Wells Fargo ...
31.03.26
Oppenheimer_Holdings in Progress Software diskutieren
Progress Software (PRGS) had its price target lowered by ...
31.03.26
Mehr anzeigen